Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BYFrontiers in neurology

A simplified Fazekas scale for efficient assessment of white matter hyperintensities.

  1. 1Department of Radiology, Linyi Hospital of Traditional Chinese Medicine, Linyi, China.

Abstract

Background

White matter hyperintensities (WMH) are key neuroimaging markers of cerebral small vessel disease (CSVD) and are associated with neuropsychiatric symptoms in older adults. Although the Fazekas visual rating scale is widely used in research, its clinical adoption remains limited. Therefore, we developed a simplified Fazekas visual rating scale (sFazekas) for overall WMH assessment to facilitate clinical application.Methods

We randomly selected 900 participants from three MRI scanners and evaluated the reliability and scoring efficiency of sFazekas versus the Fazekas scale. Then, all participants were grouped according to the sFazekas scores, and intergroup differences among the different scores were analyzed. Next, we examined correlations among the sFazekas, the Fazekas, and WMH volume. Finally, we explored associations between the sFazekas and vascular risk factors related to CSVD.Results

The sFazekas demonstrated excellent inter-rater reliability (κ = 0.851) and required significantly less time to complete than the conventional Fazekas (p < 0.01). Significant differences in age, WMH volume, and vascular risk factors were observed across sFazekas score groups (p < 0.01). The sFazekas scores were strongly correlated with Fazekas scores for both deep and periventricular white matter, as well as with WMH volume (p < 0.001). Ordinal logistic regression indicated that age, hypertension, diabetes mellitus, and a history of stroke were independent predictors of higher sFazekas scores (p < 0.001).Conclusion

The simplified Fazekas visual rating scale (sFazekas) demonstrates reliability comparable to the conventional Fazekas scale, with the practical advantage of shorter scoring time, suggesting its potential utility in the clinical assessment of overall white matter hyperintensity burden in patients with cerebral small vessel disease.

Related

  1. Visual rating versus volumetric segmentation of white matter hyperintensities for cognitive assessment: a memory clinic-based comparison and systematic review.
    Geke G C E A van Dijk, Camiel V J Box, Farog Faghir +6
    Cerebral circulation - cognition and behaviorPeer-reviewedCC BYFull textNeurologyEurope PMC
  2. Lower fibrinogen and fibrinogen-to-albumin ratio in migraine with white matter hyperintensities: implications for microvascular vulnerability.
    Aslıhan Baran
    BMC neurologyPeer-reviewedCC BY-NC-NDFull textPsychiatry & mental healthEurope PMCDOAJ
  3. White matter hyperintensities and amyloid pathology in cognitively unimpaired aging: topographical, microstructural, and network-level evidence
    Sana Mohammadi, Sana Mohammadi, Minoo Sharbafshaaer +14
    Frontiers in Aging NeurosciencePeer-reviewedCC BYFull textPsychiatry & mental healthDOAJ
  4. Impact of White Matter Hyperintensities on Reperfusion Injury and Clinical Outcome After Successful Recanalization
    Takuma Nishimoto, Fumiaki Oka, Reo Kawano +4
    Stroke (Hoboken, N.J.)Peer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMCEurope PMCPMC
  5. Diffusion-weighted imaging reversal after reperfusion therapy in acute ischemic stroke: associations with white matter hyperintensities and cerebral microbleeds
    Nora Bannert, Paula Klassen, Regina Krijatov +6
    Neurological Research and PracticePeer-reviewedCC BY 4.0Full text1 citedEpidemiology & public healthPMC
BibTeX
@article{liu2026simplified,
  title = {{A simplified Fazekas scale for efficient assessment of white matter hyperintensities.}},
  author = {Peng Liu and Songguo Liu and Chuanna Xu and Ming Zhu and Xue Liu and Xin Zhao and Bentao Wei and Qiang Li and Guang Han},
  journal = {Frontiers in neurology},
  year = {2026},
  month = oct,
  doi = {10.3389/fneur.2026.1855460},
  url = {https://europepmc.org/article/MED/42898175},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - A simplified Fazekas scale for efficient assessment of white matter hyperintensities.
AU  - Peng Liu
AU  - Songguo Liu
AU  - Chuanna Xu
AU  - Ming Zhu
AU  - Xue Liu
AU  - Xin Zhao
AU  - Bentao Wei
AU  - Qiang Li
AU  - Guang Han
PY  - 2026
DA  - 2026/10/05
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1855460
UR  - https://europepmc.org/article/MED/42898175
AB  - Background  White matter hyperintensities (WMH) are key neuroimaging markers of cerebral small vessel disease (CSVD) and are associated with neuropsychiatric symptoms in older adults. Although the Fazekas visual rating scale is widely used in research, its clinical adoption remains limited. Therefore, we developed a simplified Fazekas visual rating scale (sFazekas) for overall WMH assessment to facilitate clinical application.Methods  We randomly selected 900 participants from three MRI scanners and evaluated the reliability and scoring efficiency of sFazekas versus the Fazekas scale. Then, all participants were grouped according to the sFazekas scores, and intergroup differences among the different scores were analyzed. Next, we examined correlations among the sFazekas, the Fazekas, and WMH volume. Finally, we explored associations between the sFazekas and vascular risk factors related to CSVD.Results  The sFazekas demonstrated excellent inter-rater reliability (κ = 0.851) and required significantly less time to complete than the conventional Fazekas (p < 0.01). Significant differences in age, WMH volume, and vascular risk factors were observed across sFazekas score groups (p < 0.01). The sFazekas scores were strongly correlated with Fazekas scores for both deep and periventricular white matter, as well as with WMH volume (p < 0.001). Ordinal logistic regression indicated that age, hypertension, diabetes mellitus, and a history of stroke were independent predictors of higher sFazekas scores (p < 0.001).Conclusion  The simplified Fazekas visual rating scale (sFazekas) demonstrates reliability comparable to the conventional Fazekas scale, with the practical advantage of shorter scoring time, suggesting its potential utility in the clinical assessment of overall white matter hyperintensity burden in patients with cerebral small vessel disease.
SN  - 1664-2295
ER  -